Inspiration Healthcare Group plc

Inspiration Healthcare Group plc

IHC.L
Inspiration Healthcare Group plcGB flagLondon Stock Exchange
26.20
GBp
+0.60
- -
23.49MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.4
0.36
0.37
0.43
0.47
0.5
0.5
0.53
0.67
0.6
0.61
0.55
0.48
Basic EPS, GAAP
-0.02
-0.07
0.03
- -
0.01
0.04
0.04
0.02
0.05
0.06
- -
-0.09
-0.19
Free Cash Flow per Basic Share
0.01
-0.09
0.01
0.05
0.01
0.02
0.02
0.04
0.08
0.03
-0.14
0.02
-0.03
Dividend per Share
- -
- -
0.02
0.01
- -
- -
- -
- -
- -
0.01
0.01
0.01
- -
Book Value per Share
-1.65
-1.72
0.08
0.16
0.16
0.67
0.7
0.69
0.52
0.48
0.48
0.38
0.16
Tangible Book Value per Share
0.32
0.25
0.05
0.09
0.08
0.1
0.14
0.21
0.31
0.29
0.27
0.23
0.14
Basic Weighted Avg Shares
5
5
26
29
31
31
31
33
55
68
68
68
80
Sales/Revenue/Turnover
2
2
10
12
14
15
15
18
37
41
41
38
38
Operating Margin (%)
-4.8
-21.6
10.25
10.65
6.66
7.95
7.9
6.67
9.63
10.37
3.61
-0.48
-4.97
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
1
1
2
2
2
2
Net Income, GAAP
- -
- -
1
- -
- -
1
1
1
3
4
- -
-6
-15
Effective Tax Rate (%)
- -
- -
23.37
91.89
29.73
- -
9.52
34.9
10.15
- -
- -
- -
- -
Profit Margin (%)
-3.73
-20.3
7.87
0.1
2.18
7.89
7.12
4.12
7.61
10.31
0.66
-16.04
-39.13
Working Capital
2
1
1
2
2
3
4
7
16
17
15
13
13
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
3
7
10
10
12
Total Equity
2
1
2
3
3
4
6
11
32
35
35
29
17
Return on Invested Capital (%)
- -
- -
46.23
4.03
19.78
- -
20.93
8.72
13.54
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-22.25
0.37
6.8
- -
5.24
3.3
10.5
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
0.37
6.78
9.68
5.24
3.28
10.86
13.82
0.84
-20.69
-76.62

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
40.13%
30.09%
-42.57%
Free Cash Flow
-0.18%
-163.42%
-241.25%
Net Income, GAAP
72.08%
-385.89%
148.04%
Sales/Revenue/Turnover
18.07%
22.48%
1.65%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
41
2024
- -
- -
- -
- -
38
2025
- -
- -
- -
- -
38

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.09
2025
- -
- -
- -
- -
-0.19

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.01
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Harout Rafi Stepanian
Full Time Employees
224
Sector
Healthcare
Industry
Medical - Devices
Address
Satellite Business Village Crawley United Kingdom RH10 9NE
IPO Date
Dec 14, 2001
Business
Inspiration Healthcare Group plc is a United Kingdom-based global medical technology company that designs, manufactures, markets, and distributes devices primarily for neonatal intensive care and acute care settings; it operates through subsidiaries including Inspiration Healthcare Ltd, SLE Ltd, and Viomedex Ltd. The company offers branded products such as neonatal ventilators including the SLE1500 6-in-1 respiratory therapy system with OxyGenie closed-loop oxygen control, respiratory support devices, auto FiO2 systems, obstetrics and developmental care equipment, and pneumatic oxygen-powered life support ventilators under the Airon brand; distributed products encompass ambulatory infusion pumps, administration sets, accessories, and patient management systems from Micrel Medical for applications including parenteral nutrition, oncology, immunoglobulin therapy, antibiotic infusion, palliative care, acute pain management, and obstetrics; technology support services provide rentals, planned preventative maintenance, repairs, spare parts, and clinical training. Headquartered in Croydon, England, with a purpose-built Manufacturing and Technology Centre opened in early 2022, Inspiration Healthcare Group plc serves over 75 countries through direct sales in the UK and Ireland and a network of international distributors targeting hospitals and homecare providers in neonatal, respiratory, infusion therapies, and emergency care segments; founded in 1998 as a retailer of medical and orthopaedic goods, it shifted focus to medical technology following its name change from Inditherm plc in 2015. Recent developments include execution of the two largest export contracts in company history comprising a Middle East deal and UNICEF delivery that drove 41% revenue growth to £24.0 million in the six months ended 31 July 2025; implementation of a 'back to basics' strategy enhancing margins, reducing working capital and net debt, streamlining supply chains, and strengthening sales pipeline management amid NHS procurement delays; reinforced brand positioning with global expansion of the SLE neonatal respiratory care brand, UK NHS distribution leadership under Inspiration Healthcare, and US and international growth for Airon ventilators; and a major shareholding change with Mennen Medical Ltd acquiring 6.209% ownership.